Cargando…
Emerging Vaccine Technologies
Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emerge...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494353/ https://www.ncbi.nlm.nih.gov/pubmed/26343196 http://dx.doi.org/10.3390/vaccines3020429 |
_version_ | 1782380076351881216 |
---|---|
author | Loomis, Rebecca J. Johnson, Philip R. |
author_facet | Loomis, Rebecca J. Johnson, Philip R. |
author_sort | Loomis, Rebecca J. |
collection | PubMed |
description | Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible. |
format | Online Article Text |
id | pubmed-4494353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-44943532015-08-31 Emerging Vaccine Technologies Loomis, Rebecca J. Johnson, Philip R. Vaccines (Basel) Review Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible. MDPI 2015-05-26 /pmc/articles/PMC4494353/ /pubmed/26343196 http://dx.doi.org/10.3390/vaccines3020429 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Loomis, Rebecca J. Johnson, Philip R. Emerging Vaccine Technologies |
title | Emerging Vaccine Technologies |
title_full | Emerging Vaccine Technologies |
title_fullStr | Emerging Vaccine Technologies |
title_full_unstemmed | Emerging Vaccine Technologies |
title_short | Emerging Vaccine Technologies |
title_sort | emerging vaccine technologies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494353/ https://www.ncbi.nlm.nih.gov/pubmed/26343196 http://dx.doi.org/10.3390/vaccines3020429 |
work_keys_str_mv | AT loomisrebeccaj emergingvaccinetechnologies AT johnsonphilipr emergingvaccinetechnologies |